Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01875783 · ClinicalTrials.gov registry record · NA
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 385
- Enrollment target
NCT01875783 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 385 participants.
The verdict
NCT01875783, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 385 participants
- Enrollment target
Study Summary
The purpose of this protocol is to determine whether point of care optical coherence tomography (OCT) imaging combined with an OCT-guided retinal referral algorithm at primary diabetes care visits increases rates of retina specialist eye care for patients with diabetic macular edema. The hypothesis is that OCT imaging with an automated OCT-guided referral algorithm will enable identification of patients at risk for vision loss from diabetic macular edema and facilitate direct referral to retina specialists for more timely evaluation and treatment.
Interventions
- DEVICE OCT imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2014-03-17 |
| Est. Completion | 2016-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01875783
The ClinicalTrials.gov registry entry for NCT01875783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OCT imaging is the first listed.
NCT01875783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01875783 about?
NCT01875783 is a clinical study titled "OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits". The purpose of this protocol is to determine whether point of care optical coherence tomography (OCT) imaging combined with an OCT-guided retinal referral algorithm at primary diabetes care visits increases rates of retina specialist eye care for patients with diabetic macular edema. The hypothesis ...
What is the current status of trial NCT01875783?
This trial is currently completed. It is a NA study. The enrollment target is 385 participants. The study started on 2014-03-17. Estimated completion is 2016-07-15.
What interventions are being tested in trial NCT01875783?
The interventions under investigation include: OCT imaging (DEVICE).
Who is sponsoring clinical trial NCT01875783?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.